Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2015First federal award
$9.6MFederal grants as PI16 awards
0Patents grantedNone matched
90Papers2,007 citations
Federal awards and patents by year
AwardsPatents
16 awards · $9.6M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Jul 17, 2023 | NIH | SBIR Phase II A liver-on-chip platform to evaluate panels of clinically relevant gene variants for screening of xenobiotic compounds | $275K | Nortis, Inc. |
| Apr 28, 2022 | NIH | SBIR Phase II Rat and Canine Microphysiological Systems of the Kidney Proximal Tubule for Chemical Toxicity Screening | $804K | Nortis, Inc. |
| Jun 16, 2021 | NIH | SBIR Phase II Development of pharmacokinetic assays utilizing an organ-on-chip model of the human kidney proximal tubule | $1.0M | Nortis, Inc. |
| May 14, 2021 | NIH | SBIR Phase II Rat and Canine Microphysiological Systems of the Kidney Proximal Tubule for Chemical Toxicity Screening | $876K | Nortis, Inc. |
| Aug 20, 2020 | NIH | SBIR Phase II Rat and Canine Microphysiological Systems of the Kidney Proximal Tubule for Chemical Toxicity Screening | $252K | Nortis, Inc. |
| Aug 11, 2020 | NIH | SBIR Phase II Organ-on-Chip Approach for Assessing Tissue-specific SARS-CoV-2 Infection and Response to Antiviral Therapy | $256K | Nortis, Inc. |
| Jul 3, 2020 | NIH | SBIR Phase II Development of pharmacokinetic assays utilizing an organ-on-chip model of the human kidney proximal tubule | $1.0M | Nortis, Inc. |
| Sep 30, 2019 | NIH | SBIR Phase I Organ-on-chip based assays for personalized assessment of renal resilience in aging patients | $300K | Nortis, Inc. |
| Aug 21, 2019 | NIH | SBIR Phase II Development of pharmacokinetic assays utilizing an organ-on-chip model of the human kidney proximal tubule | $331K | Nortis, Inc. |
| Aug 15, 2017 | NIH | SBIR Phase II A microfluidic platform for modeling drug transport and cell trafficking across the blood-brain barrier | $688K | Nortis, Inc. |
| Sep 30, 2016 | NIH | SBIR Phase II A microfluidic platform for modeling drug transport and cell trafficking across the blood brain barrier | $1.4M | Nortis, Inc. |
| Sep 21, 2016 | NIH | SBIR Phase II A microfluidic platform for modeling drug transport and cell trafficking across the blood-brain barrier | $701K | Nortis, Inc. |
| May 6, 2016 | NIH | STTR Phase I Microfluidic Platform for Stem Cell Applications | $365K | Nortis, Inc. |
| Mar 21, 2016 | NIH | STTR Phase I A microfluidic quality-control assay for stem-cell derived therapies | $325K | Nortis, Inc. |
| Sep 19, 2015 | NIH | SBIR Phase II A microfluidic platform for modeling drug transport and cell trafficking across the blood-brain barrier | $225K | Nortis, Inc. |
| Apr 29, 2015 | NIH | SBIR Phase II Development of an Advanced In-Vitro Model for Angiogenesis Research and Drug Test | $740K | Nortis, Inc. |
1 patents as inventor
- US Nortis, Inc.—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#82
Awards as PI#48
Patents#505
Companies
- Nortis, Inc.Leads (SEC Form D) · Medtech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.